Key result
Novel antibodies 7D2 and 2C3 selectively bind modified cardiac troponin I without cross-reactivity.
Why the study?
ELISA kits for detecting acute myocardial infarction vary due to lack of standardized cardiac troponin I epitopes, necessitating identification of standardized epitopes.
Acute myocardial infarction (AMI) is one of the most severe cardiovascular diseases in humans, often resulting in unexpected death. Early detection is critical for patient survival. Sandwich ELISA is a common method for the detection of AMI. However, ELISA kits from different manufacturers can give different results, in part because of the lack of standardized epitopes. Therefore, the purpose of this study was to find two standardized epitopes. We predicted two antigen epitopes and respectively immunize mice to manufacture standardized monoclonal antibodies. Eight monoclonal antibodies were prepared. Monoclonal antibodies 7D2 and 2C3 were selected with high affinity, and their characteristics were explored. The results show that monoclonal antibodies 7D2 and 2C3 can both bind to various modified forms and complexes of cardiac troponin I (cTnI), were not cross-reaction with related antigens of normal human serum and can be paired. Therefore, we deem epitopes 30 to 42 and 77 to 89 standardized epitopes.
No takes yet. Share an insight, caveat, or question.
Junjie et al. (2019) studied Acute myocardial infarction (biomarker detection). Monoclonal antibodies 7D2 and 2C3 targeting cTnI epitopes was evaluated on Binding affinity and cross-reaction with related antigens. Monoclonal antibodies 7D2 and 2C3 successfully bound to various modified forms of cardiac troponin I without cross-reacting with normal human serum, identifying epitopes 30-42 and 77-89 as standardized targets.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: